Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins (original) (raw)

Summary

Immunocytochemical staining patterns for glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) were compared in cerebral cortex, basal ganglia and white matter of eight cases with hepatic encephalopathy (HE), including four cases of Wilson's disease and four of liver cirrhosis, and of eight age-matched controls, using the peroxidase-antiperoxidase method on adjacent paraffin sections. The majority of Alzheimer type II glia (Alzg II) showed prominent immunoreactivity for S100P but not for GFAP, resembling normal astrocytes of protoplasmic type; Alzg II might be interpreted as being peculiar types of reactive astrocytes retaining characteristics of protoplasmic astrocytes. A small number of Alzg II cells showed slight perinuclear immunoreactivity for GFAP; some lacked both markers. This suggests a spectrum of metabolic changes in these two proteins in Alzg II. GFAP-positive Alzg II cells were restricted to basal ganglia and white matter adjacent to grey matter, indicating that expression of GFAP in Alzg II might be modulated by local factors. Alzheimer type I cells and Opalski cells in Wilson's disease were immunoreactive for both proteins, confirming their astroglial origin and different character from that of Alzg II. In morphometric comparison, the proportion of GFAP-positive glial cells decreased in the cortex (P<0.001) but not significantly in the white matter (0.05<_P_<0.1), confirming earlier data that the prominent reduction of GFAP in HE brains is restricted to the grey matter. In the putamen, the proportion of GFAP-positive glia decreased in acquired HE (0.01<_P_<0.05) but not in Wilson's disease, probably resulting from prominent fibrous glial poliferation related to severe parenchymal damage in Wilson's disease. In contrast, glial cells immunoreactive for S100P did not significantly change (_P_>0.1) in any of the areas studied, indicating an intact glial metabolism of S100P in HE. This clear dissociation between GFAP and S100P defines Alzg II as a peculiar glial reaction with a rather selective deficit of GFAP metabolism (“gliofibrillary dystrophy”).

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

• Brun A, Dawiskiba S, Hindfelt B, Olsson JE (1977) Brain protein in hepatic encephalopathy. Acta Neurol Scand 55: 213–225
  Google Scholar
• Herpers MJHM, Budka H, McCormick D (1984) Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaptation to the microenvironment. Acta Neuropathol (Berl) 64: 333–338
  Google Scholar
• Kimura T, Budka H, Soler-Federsppiel S (1986) An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein in human brain tumors. Clin Neuropathol 5: 21–27
  Google Scholar
• Kretzschmar HA, DeArmond SJ, Forno LS (1984) An ELISA and transblot study of GFAP in hepatic encephalopathy. J Neuropathol Exp Neurol 43: 323 [abstr]
  Google Scholar
• Ludwin SK, Kosek JC, Eng LF (1976) The topographical distribution of S-100 and GFAP proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J Comp Neurol 165: 197–208
  Google Scholar
• Mossakowski MJ, Weinrauder H (1984) Immunomorphology of Wilsonian and hepatic gliopathy in vitro. Neuropathol Pol 22: 161–178
  Google Scholar
• Sobel RA, DeArmond SJ, Forno LS, Eng LF (1981) Glial fibrillary acidic protein in hepatic encephalopathy: an immunocytochemical study. J Neuropathol Exp Neurol 40: 625–632
  Google Scholar
• Sternberger LA (1979) Immunocytochemistry, 2nd edn. Wiley, New York
  Google Scholar
• Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44: 345–396
  Google Scholar
• Yamaguchi H (1980) Studies on the immunohistochemical localization of S-100 and glial fibrillary acidic proteins in the rat nervous system and in human brain tumors (in Japanese). No To Shinkei 32: 1055–1064
  Google Scholar

Download references

Author information

Author notes

1. T. Kimura
   Present address: Department of Neurology, Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, 606, Sakyo-ku, Kyoto, Japan

Authors and Affiliations

1. Neurological Institute, University of Vienna, Schwarzspanierstr. 17, A-1090, Vienna, Austria
   T. Kimura & H. Budka

Authors

1. T. Kimura
   You can also search for this author inPubMed Google Scholar
2. H. Budka
   You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Kimura, T., Budka, H. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins.Acta Neuropathol 70, 17–21 (1986). https://doi.org/10.1007/BF00689509

Download citation

• Received: 24 June 1985
• Accepted: 04 November 1985
• Issue Date: March 1986
• DOI: https://doi.org/10.1007/BF00689509

Key words